Professor Xu Rongxiang , founder and president of MEBO Group, is the inventor of MEBT/MEBO (Moist Exposed Burn Therapy/Moist Exposed Burn Ointment).
Xu earned his degree in Medical Science from Qingdao Medical University in 1982. Upon his graduation, he completed his thesis titled The Research on pathology and Medicine Application of Local Burns, in which he made the introduction of his invention - MEBT/MEBO. Since then, he has continued his professional research in Jinan 4th Hospital of Shandong Province, where he has been a surgeon and a researcher as well. In 1986, Xu quit his job in the state-owned hospital and founded his own institute in Beijing - Beijing Guangming Chinese Medicine Institute for Burns, Wounds & Ulcers, which is the main entity of MEBO Group. In 1992, due to his outstanding contribution to saving burn victims, Xu received the American Burns Victim Society Humanitarian Prize. Domestically, he was honored as State Outstanding Contribution Scientist of China by State Council and one of the first winners of China Youth Science and Technology Creative Awards.

As a researcher in burn field, Xu put forward a moist therapy for burns, contrary to the conventional dry therapy. His invention, MEBT is a kind of burn therapy designed according to traditional Chinese Medicine and modern medical science. MEBT realizes its therapeutic actions with the coordination of MEBO. With this invention, four major difficulties in burn treatment including pain, infection, deep II-degree burns cured without scar and the progressive necrosis of burn tissues have been solved, which directly results in the enhancement of total cure rate for burns from 5.7% to 92%. So far, the discovery has received many honors, such as State New Drug, State Scientific and Technological Achievement, State Invention, etc. And Xu holds two patents in USA because of MEBT/MEBO.

As a burn surgeon, Xu has rich experiences in clinical burn treatment. In 1990 when a gas explosion happened in Bangkok, Thailand, Professor Xu was assigned by Chinese Government to treat the burn patients there with his MEBT/MEBO. His great success in saving burn patients won him a good reputation as the King of Thailand highly praised his contribution by saying "the best doctors with best technique achieved best medical effects". One year later, Xu was invited by the Ministry of National Defense of Syria to help successfully treat Syrian Army patients suffering from burns. In China, Xu organized a national medical first aid network involving 4500 hospitals, whose mission is to give emergency treatment to burn patients without delay across the country. Xu is the general supervisor of the network and also responsible for giving lectures and instructions to professional doctors for free.

With years of research behind him, Dr. Xu, inventor of the therapy, found that it was through the stem cell culturing that MEBT could effectively treat burns and heal skin with regeneration. Henceforth, this significant discovery has advanced human stem cell research into the application field of organ duplication by stem cell culturing in vivo and in situ.

Recently, Professor Rongxiang XU and his team, declared that they have successfully regenerated and duplicated gastrointestinal organs by culturing stem cells in vitro. It is another significant breakthrough in terms of human organ replication, which is subsequent to their achievements of repairing and regenerating skin with full function by the culture of adult stem cells in vivo and in situ.

As one of the pioneers in the realms of stem cell research in China, Professor Rongxiang XU and his team, now forerunners in this regard, have accomplished what no other stem cell researchers have been able to do. He is the first individual to have invented an adult stem cell cultivation technique in vivo and in situ, that not only discloses the human detailed mapping process of the in vivo and in situ organ regeneration, but also initiates and accomplishes virtual regeneration and replication of skin tissues and organs. A feat that precedes the world over.

His outstanding achievements in burn study offer Xu many advantages in the study of skin care products.

Xu is also responsible for a dozen organizations: director of China National Science & Technology Center for Burns, Wounds and Ulcers, chief editor of Chinese Journal of Burns, Wounds & Ulcer Society, chief director of National Burn Treatment Network, dean of China National Burns Association (West-East), vice-chairman of Youth Federation of Central Government, vice-chairman of China National Association of Young Scientist, vice-president of Chinese Sciences Entrepreneur Association. Beside, he is member of organizations such as Standing Committee of All-China Youth Federation, International Society for Burn Injuries, etc.

MAJOR ACHIEVEMENTS

Establishing Moist Exposed Burn Therapy (MEBT), an innovation that revolutionizes burn management based on the moist environment of the wound and heals wound by regeneration.
Inventing Moist Exposed Burn Ointment, a topical drug consisting of natural ingredients and used in MEBT that has potentials to promote wound healing by regeneration with free or minimal scarring and acceptable aesthetic results.
Completing the detailed mapping process of the repair and regeneration of injured tissue and the replication of organ tissue by adult stem cells in vivo and in situ.

AWARDS

Award of Achievement for Elite, United Arab Emirates (2000)
Humanitarian Award, USA (1993)
State Outstanding Contribution Scientists of China, China (1992)
D'Honneur Exceptionnel, France (1992)
Certificate of Individual Accomplishing State Achievement of Science and Technology (MEBT/MBO), China (1990)
Certificate of State Achievements of Science and Technology (MEBT/MBO), China (1988)

PATENTS

Japan Patent, Pharmaceutical Composition for Treating Thermal Injuries of Warm Blooded Mammals Including Humans (2000)
European Patent, Composition Pharmaceutique Poure Le Traitement De Blessures Thermiquese Chez Des Mammiferes A Sang Chaud Et L'Homme (1999)
China Patent, Pharmaceutical Composition for Treating Thermal Injuries of Warm Blooded Mammals Including Humans (1999)
China Patent, Pharmaceutical Base and The Use of the Same (1999)
United States Patent, Pharmaceutical Base and The Use of the Same (1998)
United States Patent, Pharmaceutical Composition for Treating Thermal Injuries of Warm Blooded Mammals Including Humans (1995)